Skip to main content

Aquestive Therapeutics, Inc.

AQST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001398733

In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.

13F holders, Q2 2026

Institutional positions in Aquestive Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
185
+6 vs. Q1 2026
Shares held
72.0M
+111.7K (+0.2%) vs. Q1 2026
Total value
$299.5M
+$961.2K (+0.3%) vs. Q1 2026
New holders
23
69 more added
Sold out
17
45 more reduced

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AQST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 185 institutions
Q1 2021: 64 institutionsQ2 2021: 60 institutionsQ3 2021: 46 institutionsQ4 2021: 52 institutionsQ1 2022: 51 institutionsQ2 2022: 46 institutionsQ3 2022: 46 institutionsQ4 2022: 37 institutionsQ1 2023: 35 institutionsQ2 2023: 54 institutionsQ3 2023: 48 institutionsQ4 2023: 57 institutionsQ1 2024: 97 institutionsQ2 2024: 98 institutionsQ3 2024: 117 institutionsQ4 2024: 114 institutionsQ1 2025: 121 institutionsQ2 2025: 117 institutionsQ3 2025: 152 institutionsQ4 2025: 179 institutionsQ1 2026: 180 institutionsQ2 2026: 185 institutions
Value heldQ2 2026: $299.5M
Q1 2021: $86.4MQ2 2021: $62.0MQ3 2021: $64.4MQ4 2021: $62.9MQ1 2022: $40.6MQ2 2022: $10.7MQ3 2022: $18.6MQ4 2022: $13.5MQ1 2023: $17.0MQ2 2023: $31.5MQ3 2023: $21.5MQ4 2023: $48.1MQ1 2024: $176.8MQ2 2024: $110.7MQ3 2024: $232.4MQ4 2024: $154.4MQ1 2025: $127.8MQ2 2025: $157.6MQ3 2025: $369.3MQ4 2025: $467.0MQ1 2026: $298.6MQ2 2026: $299.5M
Institutions holding AQST and their total value by quarter
QuarterHoldersValue
Q2 2026185$299.5M
Q1 2026180$298.6M
Q4 2025179$467.0M
Q3 2025152$369.3M
Q2 2025117$157.6M
Q1 2025121$127.8M
Q4 2024114$154.4M
Q3 2024117$232.4M
Q2 202498$110.7M
Q1 202497$176.8M
Q4 202357$48.1M
Q3 202348$21.5M
Q2 202354$31.5M
Q1 202335$17.0M
Q4 202237$13.5M
Q3 202246$18.6M
Q2 202246$10.7M
Q1 202251$40.6M
Q4 202152$62.9M
Q3 202146$64.4M
Q2 202160$62.0M
Q1 202164$86.4M

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Aquestive Therapeutics, Inc.; share changes are against Q1 2026.

Institutions holding AQST in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
True Wealth Design, LLC0$00.00%−58−100.0%Sold out
MAI Capital Management0$00.00%−5−100.0%Sold out
CWM, LLC––––Not filed